- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Recursion Pharmaceuticals (RXRX)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 667.15 mm | 667.15 mm | 667.15 mm | 667.15 mm | 667.15 mm | 667.15 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 57.40 mm | 61.24 mm | 39.12 mm | 36.76 mm |
| Cash used (since last report) | n/a | n/a | 209.83 mm | 223.85 mm | 143.00 mm | 134.39 mm |
| Cash remaining | n/a | n/a | 457.32 mm | 443.29 mm | 524.14 mm | 532.76 mm |
| Runway (months of cash) | n/a | n/a | 8.0 | 7.2 | 13.4 | 14.5 |
| 13F holders | Current |
|---|---|
| Total holders | 316 |
| Opened positions | 86 |
| Closed positions | 38 |
| Increased positions | 114 |
| Reduced positions | 59 |
| 13F shares | Current |
|---|---|
| Total value | 2.04 tn |
| Total shares | 316.61 mm |
| Total puts | 3.64 mm |
| Total calls | 2.82 mm |
| Total put/call ratio | 1.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 34.01 mm | $229.91 bn |
| ARK Investment Management | 32.35 mm | $218.66 bn |
| Baillie Gifford & Co | 24.86 mm | $168.08 bn |
| BLK BlackRock | 23.44 mm | $158.43 bn |
| SFTBY SoftBank | 14.67 mm | $99.15 bn |
| Mubadala Investment Co PJSC | 12.99 mm | $87.78 bn |
| STT State Street | 12.58 mm | $85.03 bn |
| Kinnevik AB (publ) | 11.91 mm | $80.48 bn |
| Novo Holdings A/S | 10.11 mm | $68.37 bn |
| MIC Capital Management UK | 9.64 mm | $65.19 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Jan 26 | Blake Borgeson | Class A Common Stock | Sell | Dispose S | No | Yes | 4.36 | 220,000 | 959.20 k | 6,649,863 |
| 5 Jan 26 | Christopher Gibson | Class A Common Stock | Gift | Dispose G | No | Yes | 0 | 20,000 | 0.00 | 913,839 |
| 5 Jan 26 | Christopher Gibson | Class A Common Stock | Sell | Dispose S | No | Yes | 4.25 | 40,000 | 170.00 k | 933,839 |
| 5 Jan 26 | Christopher Gibson | Class A Common Stock | Conversion | Acquire C | No | No | 0 | 60,000 | 0.00 | 973,839 |
| 5 Jan 26 | Christopher Gibson | Class B Common Stock Class A Common Stock | Conversion | Dispose C | No | No | 0 | 60,000 | 0.00 | 4,663,334 |
| 2 Jan 26 | Zavain Dar | Class A Common Stock | Grant | Acquire A | No | No | 0 | 3,571 | 0.00 | 142,329 |
| 2 Jan 26 | Dean Y Li | Class A Common Stock | Grant | Acquire A | No | No | 0 | 2,381 | 0.00 | 1,240,909 |